-
CREST Physician Experience Survey: Evaluating the Impact of Time and Effort of Treatment Administration in Non-Muscle Invasive Bladder Cancer (NMIBC)
Sep 9, 2025, 16:22 PM -
The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review
Sep 9, 2025, 16:22 PM -
Landscape of Natural Language Processing (NLP) Capabilities at Clinical Sites: Insights From a Real-World (RW) Gastric Cancer (GC) Study
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Tipiracil Plus Bevacizumab or With Regorafenib
Sep 9, 2025, 16:22 PM -
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and Implications of Differences in Cost of Living on Global Drug Pricing Policies
Sep 9, 2025, 16:22 PM -
Impacts of Patient-Centered Collaboration: Application of a Continuous Engagement Plan Across Multiple Phases of the Insights and Patient Experiences With Cardiovascular Disease (IPEC) Initiative
Sep 9, 2025, 16:22 PM -
Meaningful Within-Patient Change of the IWQOL-Lite-CT Physical Function Composite in Adults With Obesity
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Oral Semaglutide in Thai Patients With Type 2 Diabetes: An Observational Single-Arm Multicenter Retrospective Cohort Study (REALISED)
Sep 9, 2025, 16:22 PM -
Evaluating the Reliability of Value of Information Methods: A Simulation-Based Comparison
Sep 9, 2025, 16:22 PM -
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of the Mitigation Strategies to Overcome the Risk for Confounding of Overall Survival in Trials With Crossover/Treatment Switching Evaluated in Health Technology Assessments of Treatments for Select Tumors in Oncology
Sep 9, 2025, 16:22 PM -
Are Real-World Survival Outcomes in Metastatic Breast Cancer Transportable Between the US and Austria?
Sep 9, 2025, 16:22 PM -
Colorectal Cancer Mortality Overview in Mexico 1998-2023
Sep 9, 2025, 16:22 PM -
Avacopan in the Treatment of ANCA-Associated Vasculitis: A Cost-Utility Analysis in Portugal
Sep 9, 2025, 16:22 PM -
Access to Decide on a Generalization: Results From the EVA-Corse Experiment: Efficiency and Clinical Non-Inferiority of a Hybrid Cardiac Rehabilitation Model in Corsica
Sep 9, 2025, 16:22 PM -
The Cost of Inaction: Strengthening Nutrition in Frailty Guidelines Across Europe
Sep 9, 2025, 16:22 PM -
Comparing Health-Related Quality of Life in Obese Patients With and Without Bariatric Surgery: A Cross-Sectional Study in a Multi-Ethnic Asian Population in Singapore
Sep 9, 2025, 16:22 PM -
Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Sep 9, 2025, 16:22 PM -
Cost per Responder Analysis of Teclistamab Compared to Real-World Physician’s Choice of Carfilzomib and/or Pomalidomide-Based Regimens for Triple-Class Exposed Patients With Refractory/Relapsed Multiple Myeloma
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review on Costs and Healthcare Resource Utilization in Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM